Vertex to Acquire Crinetics Pharmaceuticals

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

Vertex Pharmaceuticals Incorporated and Crinetics Pharmaceuticals, Inc.: Vertex to Acquire Crinetics Pharmaceuticals

Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio - PALSONIFY, Crinetics' recently launched, first ...
Frontiers

Integrated clinical and PBMC transcriptomic profiling identifies lipid metabolism-related candidate signatures associated with chronic brucellosis

To investigate clinical and peripheral blood mononuclear cells (PBMCs) transcriptomic features associated with chronic brucellosis and to test the hypothesis that lipid metabolism-related ...
GitHub

Sama_Dharani_dharanisama@gmail.com_Eightfold.pdf.md

The candidate intelligence platform solves the challenge of fractured applicant data by ingesting multiple structured (CSV, ATS) and unstructured (Resumes, GitHub, LinkedIn) sources. It ...
BioSpace

Drug Development

Skyhawk CEO hopes FDA’s new uniQure position will translate to Huntington’s pill A recent FDA reversal sparked new hope for patients with Huntington’s disease. Flying under the radar, Skyhawk ...